Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hisanobu Niitani

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Drug Administration Schedule

Procedures

Activities & Behaviors

Drug Evaluation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Katakami Nobuyuki; Takiguchi Yuichi; Yoshimori Kozo; Isobe Hiroshi; Bessho Akihiro; Yoshimura Akinobu; Niitani Hisanobu
Docetaxel in combination with either cisplatin or gemcitabine in unresectable non-small cell lung carcinoma: a randomized phase II study by the Japan Lung Cancer Cooperative Clinical Study Group.
Tominaga Takeshi; Nomura Yasuo; Horikoshi Noboru; Takashima Shigemitsu; Kimura Morihiko; Koyama Hiroki; Kikkawa Nobuteru; Toge Tetsuya; Mitsuyama Shoshu; Morimoto Tadaoki; Enomoto Koji; Wada Tomio; Kimishima Izo; Niitani Hisanobu;
[Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)]
Ichinose Yukito; Yoshimori Kozo; Sakai Hiroshi; Nakai Yushi; Sugiura Takahiko; Kawahara Masaaki; Niitani Hisanobu
S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hisanobu Niitani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2006: Katakami Nobuyuki; Takiguchi Yuichi; Yoshimori Kozo; Isobe Hiroshi; Bessho Akihiro; Yoshimura Akinobu; Niitani Hisanobu
Docetaxel in combination with either cisplatin or gemcitabine in unresectable non-small cell lung carcinoma: a randomized phase II study by the Japan Lung Cancer Cooperative Clinical Study Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(5):447-53.
2005: Tominaga Takeshi; Nomura Yasuo; Horikoshi Noboru; Takashima Shigemitsu; Kimura Morihiko; Koyama Hiroki; Kikkawa Nobuteru; Toge Tetsuya; Mitsuyama Shoshu; Morimoto Tadaoki; Enomoto Koji; Wada Tomio; Kimishima Izo; Niitani Hisanobu;
[Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(7):983-90.
2004: Ichinose Yukito; Yoshimori Kozo; Sakai Hiroshi; Nakai Yushi; Sugiura Takahiko; Kawahara Masaaki; Niitani Hisanobu
S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7860-4.
2004: Ichinose Yukito; Nakai Yushi; Kudoh Shoji; Semba Hiroshi; Yoshida Susumu; Nukiwa Toshihiro; Yamamoto Hidehiko; Yamane Yoshio; Niitani Hisanobu
Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4369-73.
2004: Kubota Kaoru; Watanabe Koshiro; Kunitoh Hideo; Noda Kazumasa; Ichinose Yukito; Katakami Nobuyuki; Sugiura Takahiko; Kawahara Masaaki; Yokoyama Akira; Yokota Soichiro; Yoneda Shuichi; Matsui Kaoru; Kudo Shinzo; Shibuya Masahiko; Isobe Takeshi; Segawa Yoshihiko; Nishiwaki Yutaka; Ohashi Yasuo; Niitani Hisanobu;
Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):254-61.
2003: Morita Satoshi; Ohashi Yasuo; Kobayashi Kunihiko; Matsumoto Taketoshi; Eguchi Kenji; Shibuya Masahiko; Yamaji Yasufumi; Fukuoka Masahiro; Nagao Keiichi; Niitani Hisanobu;
Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer.
Journal of clinical epidemiology 2003;56(8):744-51.
2003: Negoro S; Masuda N; Takada Y; Sugiura T; Kudoh S; Katakami N; Ariyoshi Y; Ohashi Y; Niitani H; Fukuoka M;
Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer.
British journal of cancer 2003;88(3):335-41.
2003: Takeda Koji; Negoro Shunichi; Sawa Toshiyuki; Nakagawa Kazuhiko; Kawahara Masaaki; Isobe Takeshi; Kudoh Shinzoh; Masuda Noriyuki; Niitani Hisanobu; Fukuoka Masahiro
A phase II study of topotecan in patients with relapsed small-cell lung cancer.
Clinical lung cancer 2003;4(4):224-8.
2002: Kobayashi Kunihiko; Hino Mitsunori; Fukuoka Masahiro; Takeuchi Kunio; Furuse Kiyoyuki; Yoneda Shuichi; Hasegawa Koichi; Noda Kiichiro; Kinoshita Hiroaki; Kimura Ikuro; Taguchi Tetsuo; Kanamaru Ryunosuke; Horikoshi Noboru; Niitani Hisanobu
Phase I studies of nogitecan hydrochloride for Japanese.
International journal of clinical oncology / Japan Society of Clinical Oncology 2002;7(3):177-86.
2001: Kunikane H; Kurita Y; Watanabe K; Yokoyama A; Noda K; Fujita Y; Yoneda S; Nakai Y; Niitani H
A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule.
International journal of clinical oncology / Japan Society of Clinical Oncology 2001;6(6):284-90.
2001: Furuse K; Kawahara M; Hasegawa K; Kudoh S; Takada M; Sugiura T; Ichinose Y; Fukuoka M; Ohashi Y; Niitani H;
Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.
International journal of clinical oncology / Japan Society of Clinical Oncology 2001;6(5):236-41.
2001: Kawahara M; Furuse K; Segawa Y; Yoshimori K; Matsui K; Kudoh S; Hasegawa K; Niitani H;
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer.
British journal of cancer 2001;85(7):939-43.
2000: Nagao K; Fukuoka M; Fujita A; Kurita Y; Saito R; Niitani H; Negoro S; Katakami N; Nakano M
[A phase II study of irinotecan combined with cisplatin in non-small cell lung cancer. CPT-11 Lung Cancer Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(3):413-21.
2000: Ichinose Y; Yosimori K; Yoneda S; Kuba M; Kudoh S; Niitani H
UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study Group.
Cancer 2000;88(2):318-23.
1999: Kobayashi K; Ishihara Y; Nukariya N; Niitani H; Furue H
Effects of anti-emetic drug (tropisetron) on quality of life during chemotherapy: use of a diary-type questionnaire and application of summary measures for assessment in a randomized, multicentre study. Joint Research Group for Tropisetron Double-Blind Comparative Study.
Respirology (Carlton, Vic.) 1999;4(3):229-38.
1999: Kurita Y; Yokoyama A; Matsui K; Hara N; Nakai Y; Ohhashi Y; Niitani H
[Phase I study of gemcitabine hydrochloride (LY 188011) combination therapy with cisplatin in the patients with non-small cell lung cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(7):898-907.
1998: Horikoshi N; Aiba K; Fukuoka M; Akazawa S; Sakata Y; Furuse K; Kanamaru R; Kudoh S; Konishi T; Kurihara M; Niitani H; Furue H; Tsukagoshi S; Taguchi T; Yoshida S; Ota K; Kotake T; Wakui A
[Phase I study of raltitrexed (ZD-1694)]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(13):2075-84.
1998: Taguchi T; Tsukagoshi S; Furue H; Niitani H; Noda K
[Phase I clinical study of oxaliplatin]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(12):1899-907.
1998: Masuda N; Fukuoka M; Fujita A; Kurita Y; Tsuchiya S; Nagao K; Negoro S; Nishikawa H; Katakami N; Nakagawa K; Niitani H
A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.
British journal of cancer 1998;78(2):251-6.
1998: Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T
[Phase I study of orally administered UFT plus l-leucovorin]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(4):531-9.
1998: Nishikawa H; Nakabayashi T; Nakai Y; Kurita Y; Fukuoka M; Onoshi T; Ogura T; Sakuma A; Niitani H; Tsubura E
[A clinical phase III trial of ulinastatin (MR-20) for nephrotoxicity of cisplatin]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(1):97-109.
1998: Yamamoto K; Noda K; Yoshimura A; Fukuoka M; Furuse K; Niitani H
Phase I study of E7010.
Cancer chemotherapy and pharmacology 1998;42(2):127-34.
1998: Takada M; Negoro S; Kudo S; Furuse K; Nishikawa H; Takada Y; Kamei T; Niitani H; Fukuoka M
Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study.
Cancer chemotherapy and pharmacology 1998;41(3):217-22.
1997: Taguchi T; Inuyama Y; Kanamaru R; Hasegawa K; Akazawa S; Niitani H; Furue H; Kurihara M; Ota K; Suga S; Ariyoshi Y; Takai S; Shimoyama T; Toge T; Takashima S; Sugimachi K; Hara Y; Fujita H; Kimura K; Saito T; Tsukagoshi S; Nakao I
[Phase I study of S-1. S-1 Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(15):2253-64.
1997: Ichinose Y; Yano T; Kudoh S; Yoshimori K; Morikawa T; Kuba M; Niitani H
UFT plus cisplatin in advanced non-small-cell lung cancer: interim analysis of 67 patients.
Oncology (Williston Park, N.Y.) 1997;11(9 Suppl 10):103-5.
1997: Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Ota K; Ariyoshi H; Hattori T; Sugimachi K; Tsukagoshi S
[TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(10):1253-61.
1997: Yokoyama A; Nakai Y; Yoneda S; Kurita Y; Niitani H
Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II study.
Anti-cancer drugs 1997;8(6):574-81.
1997: Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Nakao I; Ota K; Hattori T; Sugimachi K
[TUT-7 phase I clinical study. TUT-7 Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(9):1125-33.
1997: Niitani H; Fukuoka M; Furuse K; Kudoh S; Kurita Y; Ohnoshi T; Saijoh N
New drugs for the treatment of lung cancer. The Tokyo Cooperative Oncology Group.
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24 Suppl 1():117-9.
1997: Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
Seminars in oncology 1997;24(2 Suppl 7):S7-42-S7-46.
1996: Gemma A; Kudoh S; Fukuoka M; Kurita Y; Hasegawa K; Harada M; Mori K; Ariyoshi Y; Kurihara M; Furuse K; Horikoshi N; Kanamaru R; Fukuyama E; Yoneda S; Furue H; Taguchi T; Ota K; Wakui A; Tsukagoshi S; Niitani H
[Phase I study on DMDC]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(13):1799-811.
1996: Taguchi T; Furuse K; Fukuoka M; Shimoyama T; Morimoto K; Nakamura T; Furue H; Majima H; Niitani H; Ohta K; Wakui A; Nakao I; Tsukagoshi S
[LY188011 phase I study. Research Group of Gemcitabine (LY188011)]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(8):1011-8.
1996: Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
[Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(6):757-71.
1995: Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H
Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
Anticancer research 1995;15(6B):2691-5.
1995: Kanamaru R; Furue H; Taguchi T; Niitani H; Machida T; Akasaka Y; Ohta J; Suminaga M; Nukariya N
[Clinical phase III study of tropisetron capsule in the treatment of nausea and vomiting induced by carboplatin or non-platinum anti-cancer drugs]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(9):1235-44.
1995: Kondo M; Furue H; Taguchi T; Niitani H; Machida T; Akasaka Y; Ohta J; Suminaga M; Nukariya N; Kusunoki T
[Clinical phase III study of tropisetron capsule in the treatment of nausea and vomiting induced by anti-cancer drug; a placebo-controlled, multicenter, double-blind comparative study]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(9):1223-34.
1995: Seike M; Usuki J; Uematsu K; Enomoto T; Shinoda K; Yoshimori K; Fukuda Y; Kudoh S; Niitani H
[Giant cell interstitial pneumonia in a metal grinder with an abnormally high level of serum CA19-9]
Nihon Kyobu Shikkan Gakkai zasshi 1995;33(8):894-9.
1995: Yakushiji M; Tanaka H; Furue H; Taguchi T; Niitani H; Machida T; Akasaka Y; Ohta J; Suminaga M; Nukariya N
[Clinical phase II study of tropisetron capsule in the treatment of nausea and vomiting induced by anti-cancer drugs]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(8):1073-86.
1995: Niitani H
[Phase II study]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(5):607-10.
1995: Mochimaru H; Kawanami O; Kudoh S; Niitani H
[Endothelial metaplasia of the alveolar capillaries in experimental silicosis of rats]
Nihon Kyobu Shikkan Gakkai zasshi 1995;33(3):268-74.
1995: Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
[The clinical phase I study of TNP-351. The TNP-351 Research Committee]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(2):259-71.
1995: Kobayashi K; Kudoh S; Takemoto T; Hino M; Hayashihara K; Nakahiro K; Ando M; Niitani H
In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c/t curve.
Journal of cancer research and clinical oncology 1995;121(12):715-20.
1994: Kudo S; Hino M; Fujita A; Igarashi T; Arita K; Niitani H; Taguchi T
[Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(15):2617-23.
1994: Taguchi T; Furue H; Niitani H; Ishitani K; Kanamaru R; Hasegawa K; Ariyoshi Y; Noda K; Furuse K; Fukuoka M
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(12):1997-2005.
1994: Azuma A; Yagita H; Okumura K; Kudoh S; Niitani H
Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 x anti-(tumor-associated antigen) bispecific antibody.
Cancer immunology, immunotherapy : CII 1994;38(5):294-8.
1994: Niitani H; Furuse K; Fukuoka M; Hasegawa K; Taguchi T
[Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(2):177-87.
1993: Suminaga M; Furue H; Ohta K; Taguchi T; Niitani H; Ogawa N
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--multi-centered placebo-controlled double-blind comparative study]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(9):1211-9.
1993: Suminaga M; Furue H; Ohta K; Taguchi T; Niitani H; Ogawa N
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(9):1203-10.
1993: Yoshimura A; Yamano Y; Gemma A; Yoshimori K; Hayashihara K; Taniguchi Y; Uematsu K; Shibuya M; Kudoh S; Niitani H
[An early phase II trial combining cisplatin and carboplatin in advanced non-small cell lung cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(4):503-8.
1993: Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
[Phase I clinical study of TT-62. Research group of TT-62]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(2):241-6.
1993: Niitani H; Hisakatsu S
[Antimicrotubule agents]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(1):34-41.
1992: Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
[Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(12):2071-84.
1992: Ariyoshi Y; Ota K; Taguchi T; Furue H; Niitani H; Tsukagoshi S; Ikeda M; Akasaka Y; Ohta J; Suminaga M
[Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(12):2057-70.
1992: Ohta J; Taguchi T; Furue H; Niitani H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Suminaga M
[Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(12):2041-55.
1992: Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(11):1905-14.
1992: Suminaga M; Furue H; Taguchi T; Ota K; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(11):1891-903.
1992: Suminaga M; Furue H; Taguchi T; Niitani H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(11):1879-90.
1992: Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
Cancer research 1992;52(18):4890-4.
1992: Nukariya N; Niitani H; Taguchi T; Furue H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
[Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(9):1375-85.
1992: Akasaka Y; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Ohta J; Suminaga M
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(9):1359-74.
1992: Nukariya N; Niitani H; Taguchi T; Furue H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Ohta J
[Examination of anti-emetic effect, safety and usefulness of single oral dose of ondansetron tablet in nausea and emesis induced by anti-cancer drugs--dose-finding study of ondansetron tablet in patients receiving non-platinum anti-cancer drugs]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(9):1347-57.
1992: Suminaga M; Furue H; Taguchi T; Ota K; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Ohta J; Akasaka Y
[Clinical evaluation of ondansetron (injection of a single intravenous dose) against nausea and emesis associated with anti-cancer drugs--dose-finding study in patients receiving cisplatin]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(9):1333-45.
1992: Niitani H; Fukuoka M; Furusawa M; Tamura M; Hasegawa K; Kurita Y; Ariyoshi Y; Matsunaga T; Kumoi T; Kimura I
[A phase I study on a weekly schedule of DWA2114R]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(7):1027-32.
1992: Niitani H; Hasegawa K; Takizawa H; Nakano H; Yoshida S; Uchiyama T; Matsuoka T; Nagao K; Komatsu H; Sato H
[Clinical study of etoposide (NK 171s, miniaturized capsule) in advanced small cell lung cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(4):561-4.
1992: Kobayashi K; Takemoto T; Hino M; Hayashihara K; Nakahiro K; Wasai S; Niitani H
[Estimating doses of anti-cancer agents in sensitivity tests in vitro]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(3):399-403.
1992: Niitani H; Kobayashi K
Cisplatin/carboplatin therapy in non-small cell lung cancer.
Oncology 1992;49 Suppl 1():51-6.
1991: Azuma A; Niitani H
[Bi-specific F(ab')2 enhances cytolytic activities of LAK cells against human small cell lung cancer (SCLC)]
Nihon Kyobu Shikkan Gakkai zasshi 1991;29(9):1132-7.
1991: Azuma A; Niitani H; Okumura K
[Cancer therapy by using bispecific antibody]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(10):1535-42.
1991: Taguchi T; Tsukagoshi S; Furue H; Niitani H; Ohta K; Ariyoshi H; Hasegawa K; Majima H; Nakao I; Yasutomi M
[Phase I study of CI-898. CI-898 Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(10):1599-612.
1991: Kurane S; Kobayashi K; Nukariya N; Morikawa T; Hino M; Sibuya M; Niitani H
[Pilot study of multi-cyclic combination chemotherapy in small cell lung cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(3):489-92.
1990: Kobayashi K; Hino M; Hayashihara K; Niitani H
[Probability of the combination use of cisplatin and carboplatin]
Nippon Gan Chiryo Gakkai shi 1990;25(11):2684-92.
1990: Furue H; Niitani H; Nakao I; Hoshino A; Hasegawa K; Tsukagoshi S; Fujita H
[Phase I study of MST-16]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(7):1287-94.
1990: Shibuya M; Hirosawa A; Niitani H
[New treatments for urogenital toxicity of anti-neoplastic chemotherapy]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(4 Pt 2):950-6.
1990: Taguchi T; Wakui A; Hasegawa K; Niitani H; Furue H; Ohta K; Hattori T
[Phase I clinical study of CPT-11. Research group of CPT-11]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(1):115-20.
1990: Shibuya M; Niitani H; Aoyama A; Kawachi S; Nukariya N; Baba M; Iizuka K; Sakai S; Ohtsuka M
Antimetastatic effect of defibrinogenation with batroxobin depends on the natural killer activity of host in mice.
Journal of cancer research and clinical oncology 1990;116(2):168-72.
1989: Murata A; Takeda Y; Usuki J; Niitani H; Kamoi S; Araki T; Koizumi K; Syouji T; Kawanami O
[A case of pulmonary lymphangiomyomatosis induced by pregnancy]
Nihon Kyobu Shikkan Gakkai zasshi 1989;27(9):1106-11.
1989: Baba M; Shibuya M; Iizuka K; Sakai S; Hirata S; Ohtsuka M; Aoyama A; Niitani H; Koizumi K; Shohji T
[Effect of cisplatinum (CDDP) and combined chemotherapy with CDDP on peripheral blood lymphocyte natural killer (NK) activity]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(9):3299-302.
1989: Hino M; Kobayashi K; Kurane S; Nukariya N; Yamano Y; Hasegawa K; Tsuboi E; Niitani H
[A randomized phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin and adriamycin in combination with vincristine and ACNU in small cell lung cancer--THP-ADM, VCR, ACNU vs ADM, VCR, ACNU]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(9):3143-8.
1989: Kobayashi K; Hino M; Kurane S; Yano T; Niitani H; Yamano Y; Hasegawa K; Tuboi E
[A comparative randomized phase II study of CDDP, CDDP-carboquone (CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung cancer (SCLC)]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(2):207-12.
1989: Hirosawa A; Niitani H; Hayashibara K; Tsuboi E
Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
Cancer chemotherapy and pharmacology 1989;23(4):255-8.
1988: Niitani H
[Advances on ACNU in the past 10 years]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(4 Pt 1):727-31.
1987: Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
[Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(12):3345-50.
1987: Niitani H
[Bleomycin]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(11):3173-9.
1987: Hirosawa A; Sakai S; Iizuka K; Niitani H; Hayashibara K; Tsuboi E
[Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(10):2870-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hisanobu Niitani

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hisanobu Niitani (preview)

All Publications